Shield Thera Share Price (STX)

Should be this week & hopefully very positive ,enabling a further recovery in our SP

Shield Therapeutics (STX), a commercial stage pharmaceutical company specialising in iron deficiency with or without anaemia (“ID/IDA”), announced that it has entered into an exclusive licence agreement for ACCRUFeR® with VITAL-NET, Inc. in Japan. VITAL-NET will undertake and be responsible for all costs, including clinical and regulatory, related to activities required to achieve marketing authorisation and commercialisation of ACCRUFeR® in Japan. Shield will receive an initial payment of circa $665,000

We feel now is a pretty good time to analyse Shield Therapeutics plc's (LON:STX) business as it appears the company may be on the cusp of a considerable accomplishment. Shield Therapeutics plc, a commercial stage specialty pharmaceutical company, focuses on development and commercialization of clinical-stage pharmaceuticals to treat unmet medical needs. The UK£39m market-cap company announced a latest loss of US$27m on 31 December 2024 for its most recent financial year result. As path to profitability is the topic on Shield Therapeutics' investors mind, we've decided to gauge market sentiment. Below we will provide a high-level summary of the industry analysts’ expectations for the company.

Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit.

Consensus from 3 of the British Pharmaceuticals analysts is that Shield Therapeutics is on the verge of breakeven.

I don't think should be any offer for a takeover, they are not going to take a loss, they will wait when they will be in profit and then they will make a bid. Probably good 6 months results or Korea approval which is already delayed, supposedly they should get the regulatory approval for korea a year after being filed, that is last April, it's already 15 months now and still no news on that. Holding here very long time, the share pruce is undervalued in how you look at it, this is a multibagger if you have patience and wait for some more years.

Good start